Nastya Kassir

Learn More
BACKGROUND The objectives of this study were to investigate pharmacokinetic and pharmacogenetic parameters during the conversion on a 1:1 (mg:mg) basis from a twice-daily (Prograf) to once-daily (Advagraf) tacrolimus formulation in pediatric kidney transplant recipients. METHODS Twenty-four-hour pharmacokinetic profiles were analyzed before and after(More)
  • 1